Reshape Biotech
Seedtable Score
56
Startups
3
Funding Rounds
4
Investors
$27.23m
Money raised
Overview
Reshape Biotech, based in Copenhagen, shows significant potential in the lab automation sector. By creating robots to automate laboratory processes, they address issues like high labor costs, human error, and low throughput in manual lab work. Their B2B model offers tailored automation solutions, positioning them uniquely in the market. Backed by investors like R7 Partners and Y Combinator, they are well-placed to scale and capture a significant share of the health tech and robotics markets. Automation can drive efficiency and reliability for labs, making Reshape Biotech a promising industry player.
- Website: https://reshapebiotech.com
- Business model: b2b
- Company size: 11 - 51 employees
- Headquarters: Copenhagen, Denmark
- Founded: 2018
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (4)
Funding
Funding series
Funding Series Analysis
The company Reshape Biotech has raised a total of $27.23m in funding over 3 rounds.
Key Insights:
- Seed: $7.1m
- Pre Seed: $125k
- Series A: $20m
Reshape Biotech Pre Seed (2021, $0M)
$125k
Reshape Biotech Seed (2023, $7M)
$7.1m
Reshape Biotech Series A (2024, $20M)
$20m